Literature DB >> 12771952

Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.

Norio Iizuka1, Masaaki Oka, Hisafumi Yamada-Okabe, Naohide Mori, Takao Tamesa, Toshimasa Okada, Norikazu Takemoto, Kiichiro Hashimoto, Akira Tangoku, Kenji Hamada, Hironobu Nakayama, Takanobu Miyamoto, Shunji Uchimura, Yoshihiko Hamamoto.   

Abstract

Using oligonucleotide microarray data of 45 hepatocellular carcinoma (HCC) samples, we evaluated gene expression in hepatitis B virus-positive and hepatitis C virus-positive HCCs (HBV- and HCV-HCCs) for an association with liver cirrhosis (LC). In all, 89 genes were expressed differentially between HBV-HCCs associated with LC and those not associated with LC. Among them, tumors from LC patients showed significantly lower expression levels of 72 genes and significantly higher levels of 17 genes than the levels found in tumors from non-LC patients. The former included genes responsible for signal transduction, transcription, metabolism, and cell growth. The latter included a tumor suppressor gene and a cell-growth-related gene. Only eight genes were expressed differentially between HCV-HCCs associated with and without LC. Our findings provide as a framework for clarifying the role of LC in HBV- and HCV-related hepatocarcinogenesis.

Entities:  

Mesh:

Year:  2003        PMID: 12771952     DOI: 10.1038/sj.onc.1206401

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Authors:  Holger G Hass; Oliver Nehls; Juergen Jobst; Andrea Frilling; Ulrich Vogel; Stephan Kaiser
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

2.  High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma.

Authors:  Keiko Takagi; Tadatoshi Takayama; Hiroki Nagase; Masamichi Moriguchi; Xiaofei Wang; Kaname Hirayanagi; Tsukasa Suzuki; Hiromasa Hasegawa; Takanaga Ochiai; Nobuhisa Yamaguchi; Mitsugu Kochi; Makoto Kimura; Mariko Esumi
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

3.  Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.

Authors:  Li-Jen Su; Shih-Lan Hsu; Jyh-Shyue Yang; Huei-Hun Tseng; Shiu-Feng Huang; Chi-Ying F Huang
Journal:  Gene Expr       Date:  2006

4.  A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.

Authors:  Vincent W Keng; Augusto Villanueva; Derek Y Chiang; Adam J Dupuy; Barbara J Ryan; Ilze Matise; Kevin A T Silverstein; Aaron Sarver; Timothy K Starr; Keiko Akagi; Lino Tessarollo; Lara S Collier; Scott Powers; Scott W Lowe; Nancy A Jenkins; Neal G Copeland; Josep M Llovet; David A Largaespada
Journal:  Nat Biotechnol       Date:  2009-02-22       Impact factor: 54.908

Review 5.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

6.  Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.

Authors:  Frederique Caillot; Celine Derambure; Paulette Bioulac-Sage; Arnaud Francois; Michel Scotte; Odile Goria; Martine Hiron; Maryvonne Daveau; Jean Philippe Salier
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

8.  Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma.

Authors:  Celine Derambure; Cedric Coulouarn; Frederique Caillot; Romain Daveau; Martine Hiron; Michel Scotte; Arnaud Francois; Celia Duclos; Odile Goria; Marie Gueudin; Catherine Cavard; Benoit Terris; Maryvonne Daveau; Jean-Philippe Salier
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Comparative analysis of proteome and transcriptome in human hepatocellular carcinoma using 2D-DIGE and SAGE.

Authors:  Hirotaka Minagawa; Taro Yamashita; Masao Honda; Yo Tabuse; Kenichi Kamijo; Akira Tsugita; Shuichi Kaneko
Journal:  Protein J       Date:  2008-12       Impact factor: 2.371

10.  Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.

Authors:  Jong Doo Lee; Mijin Yun; Jae Myun Lee; Youjeong Choi; Youn-Hee Choi; Ji Su Kim; Se Jong Kim; Kyung Sik Kim; Woo Ick Yang; Young Nyun Park; Kwang-Hyub Han; Woo Jung Lee; Naechun Yoo; Sang Moo Lim; Jeon Han Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.